{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:35:48Z","timestamp":1793136948090,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jaad.2026.05.138","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:43:04Z","timestamp":1783600984000},"page":"e489-e490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cTopical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi Expert Panel Guidelines from ITSCC\u201d"],"prefix":"10.1016","volume":"95","author":[{"given":"Weiwei","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.05.138_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaad.2026.03.088","article-title":"Topical combined 5-Fluorouracil & calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: modified delphi expert panel guidelines from ITSCC","volume":"95","author":"Loranger","year":"2026","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.05.138_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.36849\/JDD.6632","article-title":"Use of topical calcipotriol plus 5-Fluorouracil in the treatment of actinic keratosis: a systematic review","volume":"21","author":"Mohney","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.05.138_bib3","doi-asserted-by":"crossref","first-page":"AB227","DOI":"10.1016\/j.jaad.2024.07.901","article-title":"51743 histopathological discrepancy between biopsy and mohs surgery or wide local excision carcinomas: a systematic review","volume":"91","author":"Pham","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.05.138_bib4","article-title":"Incidence of residual squamous cell carcinoma in situ on excision specimens","volume":"17","author":"Crow","year":"2024","journal-title":"Kans J Med"},{"key":"10.1016\/j.jaad.2026.05.138_bib5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaad.2024.08.039","article-title":"Combination topical 5-fluorouracil 5%\/calcipotriene 0.005% cream for the treatment of cutaneous in situ squamous cell carcinoma: a pilot study","volume":"91","author":"Patel","year":"2024","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:28:32Z","timestamp":1793136512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226030793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0190962226030793"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.05.138","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cTopical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi Expert Panel Guidelines from ITSCC\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.05.138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}